Matthew Kaplan
Stock Analyst at Ladenburg Thalmann
(2.75)
# 1,938
Out of 4,944 analysts
26
Total ratings
58.33%
Success rate
17.34%
Average return
Main Sectors:
Stocks Rated by Matthew Kaplan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UTHR United Therapeutics | Maintains: Buy | $319 → $344 | $301.39 | +14.14% | 9 | Oct 31, 2024 | |
| URGN UroGen Pharma | Maintains: Buy | $48 → $54 | $19.20 | +178.65% | 1 | Jun 14, 2024 | |
| TGTX TG Therapeutics | Maintains: Buy | $39 → $40 | $27.12 | +47.49% | 3 | May 2, 2024 | |
| LQDA Liquidia | Maintains: Buy | $15 → $30 | $24.10 | +24.48% | 2 | Dec 21, 2023 | |
| ARDX Ardelyx | Maintains: Buy | $7.5 → $8.5 | $5.60 | +51.79% | 4 | Aug 3, 2023 | |
| AVDL Avadel Pharmaceuticals | Maintains: Buy | $15 → $16 | $13.40 | +19.40% | 1 | May 2, 2023 | |
| KPRX Kiora Pharmaceuticals | Reiterates: Buy | $1,071 | $2.50 | +42,740.00% | 2 | Feb 8, 2023 | |
| XAIR Beyond Air | Maintains: Buy | $340 → $460 | $3.16 | +14,456.96% | 1 | Jun 29, 2022 | |
| LPCN Lipocine | Upgrades: Buy | $51 | $2.97 | +1,617.17% | 1 | Dec 10, 2020 | |
| COGT Cogent Biosciences | Initiates: Buy | $16 | $11.56 | +38.47% | 1 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $3.07 | +1,365.80% | 1 | Jan 22, 2020 |
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $319 → $344
Current: $301.39
Upside: +14.14%
UroGen Pharma
Jun 14, 2024
Maintains: Buy
Price Target: $48 → $54
Current: $19.20
Upside: +178.65%
TG Therapeutics
May 2, 2024
Maintains: Buy
Price Target: $39 → $40
Current: $27.12
Upside: +47.49%
Liquidia
Dec 21, 2023
Maintains: Buy
Price Target: $15 → $30
Current: $24.10
Upside: +24.48%
Ardelyx
Aug 3, 2023
Maintains: Buy
Price Target: $7.5 → $8.5
Current: $5.60
Upside: +51.79%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Buy
Price Target: $15 → $16
Current: $13.40
Upside: +19.40%
Kiora Pharmaceuticals
Feb 8, 2023
Reiterates: Buy
Price Target: $1,071
Current: $2.50
Upside: +42,740.00%
Beyond Air
Jun 29, 2022
Maintains: Buy
Price Target: $340 → $460
Current: $3.16
Upside: +14,456.96%
Lipocine
Dec 10, 2020
Upgrades: Buy
Price Target: $51
Current: $2.97
Upside: +1,617.17%
Cogent Biosciences
Oct 14, 2020
Initiates: Buy
Price Target: $16
Current: $11.56
Upside: +38.47%
Jan 22, 2020
Initiates: Buy
Price Target: $45
Current: $3.07
Upside: +1,365.80%